ECM THERAPEUTICS, INC.

Profile

Company Names

ECM THERAPEUTICS, INC.

Addresses

118 MARSHALL DRIVE, WARRENDALE, PA 15086

Phone Numbers

4122873767

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$35,219,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-05-28 
$35,219,000.00 
$40,000,000.00 
$4,781,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
BADYLAK 
EXECUTIVE OFFICER, DIRECTOR
ECM THERAPEUTICS, INC.
KATIE 
 
COLLINS 
EXECUTIVE OFFICER, DIRECTOR
ECM THERAPEUTICS, INC.
JENNA 
 
DZIKI 
EXECUTIVE OFFICER
ECM THERAPEUTICS, INC.
PAUL 
F. 
FAGAN 
EXECUTIVE OFFICER, DIRECTOR
ECM THERAPEUTICS, INC.
GEORGE 
 
HUSSEY 
EXECUTIVE OFFICER
ECM THERAPEUTICS, INC.
LINDSEY 
 
SALDIN 
EXECUTIVE OFFICER
ECM THERAPEUTICS, INC.
CHRISTINE 
 
SHEEHY 
EXECUTIVE OFFICER
ECM THERAPEUTICS, INC.   |  COEPTIS PHARMACEUTICALS, INC.   |  VININGS HOLDINGS, INC.   |  COEPTIS THERAPEUTICS INC.   |  COEPTIS THERAPEUTICS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-28 
2024-05-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-28 
2023-06-09
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-28 
2022-09-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-28 
2021-07-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-28 
2019-09-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-28 
2019-06-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-28 
2018-06-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#